glp 1 agonist lilly Diabetes Patients Also Struggle to Access GLP-1 Agonists Medscape - Orforglipron, Eli Lilly's

The evidence so far suggests that GLP-1s appear to modulate reward pathways in the brain that shape craving and compulsive drug use

K.WillerC

Reduced appetite and food noise

The outcomes assessed included glycemic control, weight management, lipid profiles, and the incidence of adverse events

GLP-1RAs provide different mechanistic effects including anti-oxidative, anti-inflammatory, and anti-atherosclerotic properties [4, 9, 11, 14, 17]

Finally, in both study cohorts, we matched combination users in chronological order, in a one to one ratio without replacement, to GLP-1 receptor agonist or SGLT-2 inhibitor users (depending on the cohort) with the same background drug, duration of use of the background drug, and propensity score